Gyre Therapeutics
7.88
+0.37
+4.93%
GYRE
02-06 16:00:00(美东时间)
高
7.90
开
7.64
量
47478股
总市值
7.59亿
低
7.58
换
0.05%
额
36.94万
市盈TTM
114.13
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
Gyre Therapeutics(GYRE)
01-10 05:05
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-26-000831 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
01-10 05:05
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-26-000832 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
01-05 20:15
$Gyre Therapeutics(GYRE)$
8-K Current report, items 7.01 and 9.01 Accession Number: 0001140361-26-000253 Act: 34 Size: 175 KB
网页链接
1赞
Gyre Therapeutics(GYRE)
2025-11-14 09:35
$Gyre Therapeutics(GYRE)$
144 Report of proposed sale of securities Accession Number: 0001985496-25-000003 Act: 33 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
2025-11-08 05:25
$Gyre Therapeutics(GYRE)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-272383 Act: 34 Size: 16 MB
网页链接
1赞
Gyre Therapeutics(GYRE)
2025-11-07 19:15
$Gyre Therapeutics(GYRE)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-270524 Act: 34 Size: 671 KB
网页链接
1赞
Gyre Therapeutics(GYRE)
2025-09-10 21:05
$Gyre Therapeutics(GYRE)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-034506 Act: 34 Size: 4 MB
网页链接
Gyre Therapeutics(GYRE)
2025-08-27 04:15
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-032719 Size: 5 KB
网页链接
1赞
Gyre Therapeutics(GYRE)
2025-08-27 04:05
$Gyre Therapeutics(GYRE)$
3 Initial statement of beneficial ownership of securities Accession Number: 0001140361-25-032710 Size: 11 KB
网页链接
Gyre Therapeutics(GYRE)
2025-08-22 19:15
$Gyre Therapeutics(GYRE)$
8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001140361-25-032295 Act: 34 Size: 185 KB
网页链接
Gyre Therapeutics(GYRE)
2025-08-12 05:15
$Gyre Therapeutics(GYRE)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-106644 Act: 34 Size: 15 MB
网页链接
Gyre Therapeutics(GYRE)
2025-08-12 04:05
$Gyre Therapeutics(GYRE)$
8-K Current report, items 2.02, 5.02, 7.01, and 9.01 Accession Number: 0000950170-25-106525 Act: 34 Size: 681 KB
网页链接
Gyre Therapeutics(GYRE)
2025-08-08 08:05
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-029693 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
2025-06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021789 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
2025-06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021793 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
2025-06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021792 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
2025-06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021791 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
2025-06-07 04:25
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021790 Size: 5 KB
网页链接
Gyre Therapeutics(GYRE)
2025-06-06 18:05
$Gyre Therapeutics(GYRE)$
8-K Current report, item 5.07 Accession Number: 0001140361-25-021612 Act: 34 Size: 169 KB
网页链接
Gyre Therapeutics(GYRE)
2025-05-30 04:05
$Gyre Therapeutics(GYRE)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020754 Size: 7 KB
网页链接